Clinical Research
Delphi-Research provides pharmaceutical companies and academic institutions with robust, reproducible, and scalable electrophysiological endpoints to drive clinical trials forward.
Standardized Endpoints
Evaluate target engagement with reproducible network biomarkers.
Trial Optimization
Stratify cohorts more precisely and cut variance between sites.
Scalable Deployment
Run identical point-of-care testing across every trial site.
Data-Rich Analytics
Access raw electrophysiological data for deeper exploration.
From pulse to report
Delphi-Research combines focused transcranial magnetic stimulation with synchronised EEG recording, then analyses the evoked responses automatically. Every session follows the same protocol, so results stay comparable across visits, sites and cohorts.
- Focused magnetic pulses are delivered to predefined cortical targets
- TMS-evoked potentials are recorded across the scalp and processed automatically
- Network measures are compared against an age-correlated normative database
- A quantitative report is produced at the point of care, with no manual scoring
.jpg)
Endpoints for trials
Delphi-Research offers pharmaceutical researchers a powerful tool to evaluate the pharmacodynamic effects of CNS-targeted therapies. By delivering accurate, repeatable data on brain network function, Delphi-Research can aid in patient selection, streamline efficacy evaluation, enhance target engagement, and potentially reduce reliance on delayed or subjective behavioral endpoints. Its non-invasive, rapid assessment format helps accelerate clinical trials, supports long-term medication monitoring, and optimizes protocols.